These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22407764)

  • 1. The tumour suppressor and chromatin-remodelling factor BRG1 antagonizes Myc activity and promotes cell differentiation in human cancer.
    Romero OA; Setien F; John S; Gimenez-Xavier P; Gómez-López G; Pisano D; Condom E; Villanueva A; Hager GL; Sanchez-Cespedes M
    EMBO Mol Med; 2012 Jul; 4(7):603-16. PubMed ID: 22407764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming.
    Romero OA; Verdura S; Torres-Diz M; Gomez A; Moran S; Condom E; Esteller M; Villanueva A; Sanchez-Cespedes M
    Oncogene; 2017 Mar; 36(9):1287-1296. PubMed ID: 27593925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRG1 and BRM function antagonistically with c-MYC in adult cardiomyocytes to regulate conduction and contractility.
    Willis MS; Holley DW; Wang Z; Chen X; Quintana M; Jensen BC; Tannu M; Parker J; Jeyaraj D; Jain MK; Wolfram JA; Lee HG; Bultman SJ
    J Mol Cell Cardiol; 2017 Apr; 105():99-109. PubMed ID: 28232072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.
    Romero OA; Torres-Diz M; Pros E; Savola S; Gomez A; Moran S; Saez C; Iwakawa R; Villanueva A; Montuenga LM; Kohno T; Yokota J; Sanchez-Cespedes M
    Cancer Discov; 2014 Mar; 4(3):292-303. PubMed ID: 24362264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
    Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR
    Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
    Padilla-Benavides T; Nasipak BT; Paskavitz AL; Haokip DT; Schnabl JM; Nickerson JA; Imbalzano AN
    J Biol Chem; 2017 Nov; 292(45):18592-18607. PubMed ID: 28939766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SWI/SNF chromatin remodeling complex regulates myocardin-induced smooth muscle-specific gene expression.
    Zhou J; Zhang M; Fang H; El-Mounayri O; Rodenberg JM; Imbalzano AN; Herring BP
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):921-8. PubMed ID: 19342595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer.
    Medina PP; Sanchez-Cespedes M
    Epigenetics; 2008; 3(2):64-8. PubMed ID: 18437052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAF60A mediates interactions between the microphthalmia-associated transcription factor and the BRG1-containing SWI/SNF complex during melanocyte differentiation.
    Aras S; Saladi SV; Basuroy T; Marathe HG; Lorès P; de la Serna IL
    J Cell Physiol; 2019 Jul; 234(7):11780-11791. PubMed ID: 30515787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock transcription factor (Hsf)-4b recruits Brg1 during the G1 phase of the cell cycle and regulates the expression of heat shock proteins.
    Tu N; Hu Y; Mivechi NF
    J Cell Biochem; 2006 Aug; 98(6):1528-42. PubMed ID: 16552721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
    Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
    Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel role of Brg1 in the regulation of SRF/MRTFA-dependent smooth muscle-specific gene expression.
    Zhang M; Fang H; Zhou J; Herring BP
    J Biol Chem; 2007 Aug; 282(35):25708-16. PubMed ID: 17599918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.
    Wang X; Sansam CG; Thom CS; Metzger D; Evans JA; Nguyen PT; Roberts CW
    Cancer Res; 2009 Oct; 69(20):8094-101. PubMed ID: 19789351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.
    Schallenberg S; Bork J; Essakly A; Alakus H; Buettner R; Hillmer AM; Bruns C; Schroeder W; Zander T; Loeser H; Gebauer F; Quaas A
    BMC Cancer; 2020 Jan; 20(1):12. PubMed ID: 31906887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPM and BRG1 Mediate Transcriptional Resistance to Retinoic Acid in Acute Promyelocytic Leukemia.
    Nichol JN; Galbraith MD; Kleinman CL; Espinosa JM; Miller WH
    Cell Rep; 2016 Mar; 14(12):2938-49. PubMed ID: 26997274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth.
    Bossen C; Murre CS; Chang AN; Mansson R; Rodewald HR; Murre C
    Nat Immunol; 2015 Jul; 16(7):775-84. PubMed ID: 25985234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.